Flat or lost cheek volume: what helps (and what to skip)
Volume loss and sagging look similar in the mirror. They need opposite treatments.
Medical review pending · 14 sources
Illustrative purposes only. Not a tool for self-diagnosis.
What this actually is
“Hollow points to lost volume. Lower points to descent.”
Flat cheeks can mean several quite different things, and they do not all need the same answer. Some of them need no answer at all.
The mid-face, the zone running from under the eye across the cheekbone, is the structural keystone of the face. When it changes, everything around it looks different: under-eyes shadow, the folds beside the nose deepen, and the face reads as tired even on a day when you feel fine.
But "flat" covers four separate situations. Some faces have lost genuine volume, because the fat pads under the skin shrink and the bone beneath them thins with age. Some have lost no volume at all: the tissue has slid downwards, so the cheek sits lower and heavier than it used to. Some have lost bony support underneath. And a great many faces are simply naturally flat-cheeked, or slim, or being photographed under unkind light.
Those situations need close to opposite treatments. The commonest expensive mistake in this entire area is adding volume to a face that is actually descending, which is exactly what produces the over-filled look most people can spot across a room.
So the first job of this page is not to point you at a treatment. It is to help you work out which of the four you are looking at, because that one question changes the right answer more than any product choice does.
“Is this me?” self-check
Before anything else, work out which kind of "flat" you have. Two questions do most of the sorting. Has your face actually changed, or has it always looked like this? And if it has changed, is it hollower, or is it lower? Hollow points towards lost volume. Lower and heavier points towards descent. They are treated in opposite ways, so this is worth getting right.
Which kind is yours?
Hollow points to lost volume. Lower and heavier points to descent. They need opposite treatments.
True volume loss
Deflation
The fat pads under the cheek shrink and the bone beneath thins, so there is genuinely less filling the mid-face. You would recognise it as hollowing rather than sagging: shadows that soften when you smile or lie flat, sharper cheekbones and temples, a face that has deflated while the jaw and neck stayed much the same. This is the presentation that responds well to added volume.
Tell-tale signs
hollow, not saggy
shadows soften lying flat
sharper cheekbones and temples
Rapid weight loss
Including on GLP-1 medication
A distinct version of the same thing, and increasingly common. Fat is lost from the face along with the rest of the body, so cheeks, temples and under-eyes hollow, bones sharpen, and people report looking older at a healthier weight. It is not unique to any one drug; it has followed rapid weight loss of every kind for decades. Timing matters more than product choice here.
Tell-tale signs
recent, rapid weight loss
temples and under-eyes too
older at a healthier weight
Descent and laxity
Heavy, sliding, tired
The cheek pad and its supports drift downwards. The tell is heaviness rather than hollowness: the cheek sits lower, the distance between eye and cheek lengthens, folds deepen, and gently lifting the skin upwards in the mirror restores the look you remember. Better lying down, worse standing up. Adding volume here makes it worse, not better.
Tell-tale signs
heavier, not hollower
lifting the skin looks better
worse standing up
Nothing is wrong
Normal variation, or the lighting
Naturally flat or high-set cheekbones, a genuinely slim face, or harsh overhead light and phone-lens distortion. The tell is that nothing has actually changed over time, and the flatness shows up in some photos and not others. There is no problem here to treat. Filler in this situation changes your face shape; it does not improve it.
Tell-tale signs
nothing has changed
only in certain photos
slim build
How much of this is the lighting?
The same face under harsh overhead light and under even, front-on light can look like two different faces. Phone lenses distort close up, too. Before deciding anything, check how your cheeks look in daylight, straight on, rather than in the photo that prompted the worry.
If the flatness disappears in even light, that is a photography effect, not a change in your face.
You may not need treatment
Illustrations of the different patterns, not before-and-after photographs. Many faces show more than one.
Match the kind to the plan
True volume loss
Volume replacement: filler, biostimulator or fat transfer.
Rapid weight loss
Wait for a stable weight first, usually several months.
Descent and laxity
A surgical opinion. Volume added here adds weight to tissue already falling.
Nothing is wrong
Nothing. Sun protection and good skincare, if you want a plan at all.
A reference, not a treatment picker. Many faces show both hollowing and heaviness, which is exactly why an assessment beats guessing from a mirror.
What’s causing it
Fat pads shrink
Fat pads lose volume
Fat pads slide
What remains slides downward
Bone resorbs
The scaffold underneath loses projection
Skin loosens
The covering no longer holds tissue in place
The mid-face is built in layers: bone at the base, deep and superficial fat pads above it, then muscle, then skin. Ageing works on all of them at once, which is why the change is rarely just one thing.
The fat pads shrink and shift. They lose volume, and the ones that remain slide downward rather than staying stacked neatly over the cheekbone. That combination is why hollowing above and heaviness below so often arrive together.
The bone underneath resorbs. The upper jaw and the bony rim around the eye socket quietly lose projection over decades. The scaffold the soft tissue sits on gets smaller, so the whole mid-face flattens and steps back, even in someone whose weight has never changed.
The skin envelope loosens. Collagen and elastin decline, so the covering no longer holds tissue in position. Sun exposure and smoking accelerate this considerably.
Rapid weight loss removes facial fat too. Facial fat is not spared when body fat drops quickly, and the face has very little to give. This is why a healthier body can arrive alongside a gaunter face, and why the current wave of GLP-1 weight loss is bringing a lot of people to this question at once. Some volume can look better again once weight stabilises, which is a large part of why waiting matters.
Most people are a mixture: some deflation, some early descent, sometimes bone change as well. That mixture is precisely why "just add filler" fails so often, and why an honest assessment is worth more than any product recommendation.
When to see a GP or dermatologist first
For most people this is a cosmetic question. There are a few situations, though, where the honest answer is a doctor rather than a clinic, and one of them is a genuine emergency. Please read this section before booking anything.
After cheek filler: increasing or one-sided pain, skin going white, or a dusky, mottled, net-like pattern. Seek urgent help now.
After cheek filler: any change in your vision, however brief. This is an emergency. Go to A&E immediately.
After cheek filler: severe or lopsided swelling, spreading redness, or fever. These can signal infection and need same-day assessment.
New or fast-progressing hollowing alongside unintentional weight loss, appetite loss, night sweats or other symptoms. See a GP first.
Facial wasting in a medical context, such as HIV-associated or medication-related lipoatrophy. This belongs with your medical team.
You are still actively losing weight. Volume restoration should generally wait for a stable baseline, usually several months.
Repeated mirror-checking, goals that keep shifting, or seeking more filler to fix filler. Worth pausing and talking to someone.
There is no NHS route for cosmetic cheek volumisation; it is not NHS-funded, and it should not be. The NHS role here is investigating an underlying medical cause of genuine facial wasting, and treating complications. If you develop signs of a vascular blockage after filler, that is urgent medical care, not a cosmetic complaint: contact your treating practitioner immediately and go to A&E if you have any visual symptoms. In England it is a criminal offence to give cosmetic filler or botulinum toxin to anyone under 18, including arranging or booking it, and consent makes no difference.
Read about filler complications
Treatment options
Read this before the options. They split by driver, not by popularity. If your driver is descent, the volumising cards are not for you, and stacking them will make things worse. If nothing has actually changed, You may not need treatment is your section, not this one. All fillers and biostimulators here are CE/UKCA-marked devices rather than prescription medicines, which is why they can be discussed and priced openly. The dissolver used in an emergency, hyaluronidase, is a prescription medicine and is handled in costs.
For genuine volume loss
Hyaluronic acid filler
Volumising, dissolvable
Well Established
HA filler · Volume replacement
Sep 2026
What it can doReplaces lost volume immediately and predictably over the cheekbone, and can be shaped in stages. Its real advantage is that it is dissolvable, so a result you dislike is not permanent.
What it can’t doLift a descending mid-face. Stacking more of it against sagging is the classic route to a heavy, over-filled result.
Safety note: cheek and mid-face injection carries a rare but serious risk of vascular occlusion, including skin death and, through a facial artery, permanent blindness. Read about filler complications.
View the evidence rationale
Well Established on randomised trials and meta-analyses with partial independent corroboration, plus a long device safety record; user experience concurs.
Key studies
Safia et al., 2025. Systematic review and meta-analysis of HA fillers for midface augmentation; 14 studies reviewed, 5 randomised trials pooled (748 participants), with significantly higher responder rates than control and high heterogeneity. Medicina. Journal ↗
Explore the treatment
Poly-L-lactic acid
Sculptra
Well Established
PLLA · Diffuse volume
Sep 2026
What it can doStimulates your own collagen over a course of sessions, restoring diffuse volume across the whole mid-face rather than a single projected point. Well suited to generalised hollowing after weight loss. Results build over months.
What it can’t doGive you an instant answer, or be reversed if you dislike it. Patience is part of the deal.
View the evidence rationale
Well Established on a multicentre randomised trial with volumetric subgroup data, though the pivotal evidence is largely manufacturer-linked.
Key studies
Prospective, multicentre, randomised, evaluator-blinded trial of poly-L-lactic acid, 2025, with a cheek-wrinkle subgroup (NCT04124692). Largely manufacturer-linked (Galderma). Full text ↗
Explore the treatment
Calcium hydroxylapatite
Radiesse
Well Established
CaHA · Structural support
Sep 2026
What it can doProvides firmer structural support, which suits a mid-face that has lost bony projection rather than just softness. Two decades of clinical use behind it.
What it can’t doBe dissolved. There is no reversal agent, so practitioner judgement and conservative placement matter more here than with HA.
View the evidence rationale
Well Established on a long clinical record plus independent reviews for volume and structural support.
Explore the treatment
Fat transfer
Autologous, surgical
Well Established
Fat transfer · Durable volume
Sep 2026
What it can doUses your own fat, and lasts longest of anything here for the portion that survives. The closest option to a lasting answer for significant deflation.
What it can’t doGuarantee how much stays. A substantial and unpredictable share is reabsorbed, and this is surgery with a real recovery, not a lunchtime appointment.
View the evidence rationale
Well Established on clinical studies and systematic reviews, with retention honestly reported as partial and variable: roughly 32 to 41% at 16 to 17 months.
A surgical route, discussed with a plastic surgeon; there is no bookable page.
For descent and laxity
Surgical lift
Deep-plane, SMAS or mid-face lift
Well Established
Surgical lift · Repositions tissue
Sep 2026
What it can doReposition tissue that has genuinely dropped. It is the only thing on this page that reliably does so, and satisfaction in the published surgical literature is high.
What it can’t doBe made non-surgical. It carries anaesthetic risk, real recovery and real cost, and it is not the right answer for mild change.
View the evidence rationale
Well Established on outcome and satisfaction studies, including recent systematic reviews and meta-analyses of modern facelift techniques.
Key studies
Vayalapra et al., 2025. Systematic review and meta-analysis comparing SMAS and deep-plane facelift techniques (47 studies, 10,766 patients); both showed significant aesthetic improvement with comparable safety profiles. Ann Plast Surg. Journal ↗
This sits outside our directory, and we still name it, because it is the honest answer for significant descent.
HIFU
Micro-focused ultrasound
Emerging
HIFU · Mild laxity
Sep 2026
What it can doProduce modest tightening in mild laxity with good skin quality, building over a few months. A reasonable trial if expectations are set low.
What it can’t doSubstitute for a lift. It is marketed as a facelift alternative more aggressively than almost anything else in aesthetics, and the evidence does not support that framing.
View the evidence rationale
Emerging on small, short-term independent studies with modest effect sizes; long-term mid-face data are largely absent.
Explore the treatment
Thread lifts
PDO or PLLA threads
Limited
Thread lifts · Short-lived
Sep 2026
What it can doProduce a short-lived repositioning effect that some people are happy with in the months immediately afterwards.
What it can’t doDeliver a surgical result. The evidence is conflicting and short-term, and the minor-complication rate is meaningful: dimpling, thread migration and visibility are all documented.
View the evidence rationale
Limited because independent evidence conflicts and a complications signal is present; it is the most oversold lift-equivalent in this concern.
Explore the treatment
Sold for this, but not a volumiser
Skin boosters
Profhilo and polynucleotides
Limited
Boosters, polynucleotides · For volume
Sep 2026
What it can doImprove skin quality, hydration and surface texture. Genuinely useful alongside a volumising plan if skin quality is part of what is bothering you.
What it can’t doRestore lost cheek volume. Reputable sources state plainly that Profhilo is not a volumiser. Being sold one of these as a fix for flat cheeks is a straightforward mis-sell.
View the evidence rationale
Limited for this concern specifically, on an absence of volume evidence; the available skin-quality studies are low to moderate quality.
Key studies
Lampridou et al., 2025. Systematic review of polynucleotides in aesthetic medicine (9 low-to-moderate-quality studies, 219 patients); skin-quality outcomes only, with limited consensus. J Cosmet Dermatol. PubMed ↗
Explore bio-remodelling
Also offered, and covered on their own pages rather than here: PCL filler (Ellansé), Emerging for the cheek specifically, where cheek data are extrapolated from fold data, and not dissolvable; RF microneedling, better understood as skin tightening than lifting, and subject to an FDA safety communication of 15 October 2025 covering burns, scarring, fat loss and nerve damage; RF skin tightening; and Endolift, mostly lower-face evidence.
The honest ceiling
Here is the limit, stated plainly, because naming it is more useful than working around it.
Fillers and biostimulators replace volume. They do not lift.
If your mid-face has genuinely dropped, nothing injectable puts it back where it was. The gap between marketing and evidence is wider here than anywhere else on this site: every "non-surgical facelift" claim, whether thread, ultrasound, radiofrequency or stacked filler, over-reaches on real descent. Only surgery repositions tissue.
There is a point where adding volume stops helping and starts hurting.
In a mid-face that is descending rather than deflating, more volume adds weight to tissue that is already falling. The result is the puffy, over-filled look the public recognises instantly. That look is almost never one bad injection. It is the accumulated result of treating descent as though it were deflation, session after session.
Everything non-surgical is managed, not cured.
Hyaluronic acid lasts roughly 12 to 18 months in the mid-face, sometimes closer to two years. Biostimulators can reach around two years. Energy-device tightening is measured in months. Ageing continues underneath all of it, so results are maintained by repeating, at repeating cost.
And if your cheeks have always been flat, the ceiling is that there is nothing to treat.
Filler will change your face shape. It cannot turn a healthy anatomical variation into a corrected one.
Commonly oversold / myths
The claim
"A liquid facelift. Same result as surgery, no downtime."
Reality: This is the most persistent myth in aesthetics, and it fails on the basic mechanics. Filler adds volume; a facelift repositions tissue. They are different actions on different problems. Threads and ultrasound devices are sold on the same promise and deliver, at best, modest and temporary tightening. If descent is your driver, the honest options are a surgical opinion, accepting the change, or targeting something else entirely.
The claim
"Profhilo or polynucleotides will restore your cheek volume."
Reality: They will not. These are skin-quality treatments, and reputable sources state explicitly that Profhilo is not a volumiser. They can sit sensibly alongside a volumising plan if your skin quality is also bothering you, but sold as a volume fix for flat cheeks this is a straightforward mis-sell, and a fairly common one.
The claim
"More is better. And start young, so you never lose volume in the first place."
Reality: Over-volumising is the main long-term harm in this whole area, and there is no evidence that "preventative" cheek filler in a young, unchanged face prevents anything. What it does reliably start is a maintenance cycle with an open-ended cost. Be wary of automatic millilitre recommendations, multi-area packages, and any consultation that arrives at an amount before it arrives at an assessment.
The claim
"Fix your weight-loss face now, before it settles."
Reality: Urgency framing around rapid weight loss is a red flag rather than clinical advice. Treating while your weight is still moving means restoring against a shifting baseline, and some facial fullness does return once weight stabilises. Filler also addresses lost volume, not loose skin, which is a different part of the same problem. Waiting for a stable baseline is usually the better plan, not the cautious one.
The claim
"It's completely safe. No risk, no downtime."
Reality: Cheek and mid-face filler carries a rare but serious risk of vascular occlusion, which can cause skin death and, if product enters an artery supplying the eye, permanent blindness. That risk is small and it is real, and a practitioner who tells you otherwise has told you something important about how they practise. Read about filler complications.
You may not need treatment
Protect
+
Wait for stability
+
Skin quality
For a good proportion of people reading this, the honest answer is nothing, and we would rather say so here than bury it.
If your face has not actually changed, if the flatness appears in some photos and vanishes in even light, if you are slim and always have been, then what you have is a face shape rather than a problem. Filler in that situation does not improve the face; it changes it, usually by widening it, and it starts a commitment you did not need to make.
If you are in the middle of losing weight, the answer is not "no" but "not yet". Wait for a stable baseline, usually several months of steady weight. Adequate protein and some resistance training during weight loss help protect lean mass, and losing weight more gradually where you can reduces the deflation shock.
No cream, serum, device or facial exercise restores lost cheek volume. Nothing topical reaches the fat pads or the bone. What good skincare does do is protect the skin envelope sitting over whatever volume you have, which is a genuine and worthwhile goal in itself. Face exercises, gua sha and massage tools sold to "lift" or "rebuild" cheeks have no reliable evidence behind those claims. Pleasant, possibly relaxing, not a volume treatment. The framing here is "what to look for", not "buy this brand".
The foundation
SPF / sunscreen
The highest-value habit here. Sun exposure degrades the skin envelope over any lost volume, and protects whatever procedural result you may have later.
Active ingredient
Retinoids / retinol
Supports skin quality and firmness over months. Prescription-strength versions are prescription-only, with no price or promotion shown here.
Active ingredient
Vitamin C
A reasonable antioxidant adjunct to sun protection for overall skin quality. Not a volumiser, and not sold here as one.
Deeper skin belongs at the centre
Everything on this page applies across all skin tones, and two things need saying specifically for Fitzpatrick IV to VI.
Injections can leave marks. Any needle entry into deeper skin can trigger post-inflammatory hyperpigmentation, usually as small dark spots at the entry points. It is not a reason to avoid treatment, and it is a reason to ask about technique. Fewer entry points and gentle handling reduce trauma, and a cannula rather than a needle may reduce it further where the anatomy suits. Be aware that cannula safety against vascular events specifically can be overstated: recent data caution against treating it as a guarantee. This is a judgement about your anatomy and the practitioner's experience, not a box to tick.
Energy devices vary sharply. For the laxity side of this concern, ablative and some non-ablative lasers carry the highest pigment risk in deeper skin and need conservative settings and test patches. Insulated-needle radiofrequency microneedling and Sofwave have relatively more favourable profiles across skin tones, though the FDA's October 2025 safety communication on radiofrequency microneedling, covering burns, scarring, fat loss and nerve damage, applies to every skin type. Conservative settings and an experienced operator matter regardless of tone.
If your skin scars keloid or hypertrophic, anything that breaks the skin, including threads and surgery, deserves a longer conversation before you agree to it.
None of this is a reason to be treated more cautiously than you want to be. It is a reason to choose the device, the setting and the operator deliberately.
Costs and what to expect
Two things to hold in mind. Non-surgical volume is a repeating cost, not a purchase, so budget for the ongoing commitment rather than the first appointment. And the cheapest option on this page is the one where you decide you do not need anything. Prices are indicative for 2026, private, and not NHS-funded. Verify at booking.
Option
Indicative 2026 price
Notes
Consultation (doctor-led benchmark)
~£75
Often redeemable against treatment. An assessment that separates deflation from descent is the most valuable thing you will buy here.
HA volumising filler
~£350–£600+ per syringe
Usually 1 to 2 syringes. Lasts around 12 to 18 months, sometimes closer to 2 years in the mid-face. Reversible.
CaHA (Radiesse)
~£350–£550 per syringe
1 to 2 syringes, around 12 to 18 months. Not reversible.
PLLA (Sculptra)
~£600–£900 per vial
A course of 2 to 3 sessions, 4 to 6 weeks apart. Results build over months and last up to around 2 years. A full course costs considerably more than one vial.
PCL (Ellansé)
~£450–£700 per syringe
One session, roughly 1 to 4 years depending on formula. Not reversible.
Autologous fat transfer
~£2,500–£6,000+
Surgical, one session plus possible touch-up. Retention is partial and variable.
HIFU (Ultherapy / Sofwave)
~£1,500–£3,500+
Usually one session; effect builds over 2 to 6 months and lasts around a year. For mild laxity only.
RF-microneedling
~£500–£1,500 per session
Around 3 sessions. Subject to the FDA safety communication of October 2025.
Thread lifts
~£1,000–£2,500
Effect around 6 to 12 months. Evidence is conflicting and complications are documented.
Surgical lift (deep-plane / SMAS)
~£8,000–£20,000+
One procedure, durable for roughly 10 to 15 years with a deep-plane technique. Outside our directory; named because it is the honest ceiling.
Hyaluronidase (dissolving filler)
Prescription only, price not publicly advertised
A prescription medicine. Since 1 June 2025 it cannot be prescribed without a face-to-face consultation, which is why your injector's emergency arrangements matter.
Nothing on this page is NHS-funded. The NHS role is investigating a medical cause of genuine facial wasting, and treating complications.
Indicative 2026 prices · verify at booking.
The emotional side
A face shaped by genetics, by a healthier weight, or by ordinary ageing is not a defect awaiting correction.
Flat or slim cheeks are not a flaw, and it is worth saying that plainly on a page like this one.
Several very different feelings bring people here. There is the comparison version: years of contoured and filtered faces making normal anatomy start to look like a deficiency. There is the weight-loss version, where a body you worked hard for arrives with a face that looks depleted, and the loss feels oddly like a betrayal. There is the ageing version, where nothing dramatic has happened and yet the mirror keeps reporting tiredness you do not feel. And there is the aftermath version, where a result you did not want has left you checking your face repeatedly and unsure who to trust. All of those are legitimate. None of them, on their own, means a treatment is the answer.
What is worth watching for is when the feeling starts running the decision: constant mirror or photo checking, goals that keep moving, a preoccupation out of proportion to the change, or seeking out more filler to fix filler. That pattern tends to lead to more treatment and less satisfaction, not the other way round.
If it is dominating your days
If how you feel about your face is dominating your days, or you find yourself checking or avoiding constantly, a GP is a reasonable first step. This is common with visible change, it is not vanity, and support exists and works.
If it is hard to interrupt
Where preoccupation with a perceived flaw is severe, hard to interrupt, and disproportionate to what others see, that pattern is recognised and treatable. More procedures typically make it worse. A GP can help you find the right support.
NHS: body dysmorphic disorder
If you are under 18
If you are under 18, cosmetic filler and botulinum toxin are not lawfully available to you in England, and consent makes no difference to that. Faces also change a great deal into the twenties. A GP or a trusted adult is the right first conversation, not a clinic.
Frequently asked questions
Are flat cheeks a flaw, or just a face shape?
For a lot of people, just a face shape. If your cheeks have always looked like this and nothing has changed over the years, you are looking at normal anatomy, not a problem. Filler would change your face shape rather than improve it. The honest test is whether the flatness is a change over time or a constant, and whether it survives even, front-on lighting.
Will cheek filler lift my face, or just add volume?
Just add volume. Filler replaces what has deflated; it does not reposition tissue that has dropped. If the change you have noticed is heaviness rather than hollowness, adding volume tends to make it heavier still. That mismatch, repeated over several sessions, is what produces the over-filled look people recognise instantly. Only surgery reliably lifts a mid-face that has genuinely descended.
Should I wait to treat my face after weight loss until my weight is stable?
Usually yes. Treating while your weight is still moving means restoring volume against a shifting baseline, and some facial fullness returns once weight stabilises. Several months of steady weight is a reasonable rule of thumb. Anyone framing this as urgent is selling, not advising. Adequate protein and resistance training during weight loss also help protect lean mass.
How do I tell the difference between volume loss and sagging?
Two quick checks. Does the hollowing soften when you smile or lie flat? That points to lost volume. Does gently lifting the skin upwards in the mirror look like the face you remember, and does everything look better lying down than standing? That points to descent. Many people have both, which is exactly why a proper assessment beats guessing from a mirror.
Can Profhilo or polynucleotides restore lost cheek volume?
No. They are skin-quality treatments, and reputable sources say plainly that Profhilo is not a volumiser. They can improve hydration and surface quality, which is a real benefit if that is what is bothering you, and they can sit alongside a volumising plan. Sold to you as a fix for flat cheeks, though, this is a mis-sell worth walking away from.
What warning signs after cheek filler mean I need urgent help?
Increasing or one-sided pain, skin turning white, a dusky or mottled net-like pattern on the skin, severe or lopsided swelling, fever, and above all any change in your vision. These can signal a blocked blood vessel or infection, and both are time-critical. Contact your practitioner immediately, and go to A&E for any visual symptom. Do not wait to see whether it settles.
Citations & sources
14 sources
Citations & sources
14 sources
Medical review and reference verification are pending.
1. Sharma RK et al. Radiographic midfacial volume changes in patients on GLP-1 agonists. Otolaryngology–Head and Neck Surgery, 2025. Small cohort (n=20); presented as an early signal, not a population figure.
2. University College London, published in BMC Medicine, January 2026. Estimated UK adult uptake of GLP-1 weight-loss medication in the year to early 2025; higher use in women, peak ages 45 to 55.
3. Systematic review and meta-analysis of hyaluronic-acid filler efficacy, PRISMA, Medicina (MDPI), 2025. 14 studies, 5 pooled randomised trials, n=748; higher responder rates versus control, with high heterogeneity. Mixed independent and manufacturer-funded evidence.
4. Network meta-analysis of HA fillers, 6 randomised trials, n=579.
5. Prospective, multicentre, randomised, evaluator-blinded trial of poly-L-lactic acid (PMC12273185, 2025), with Cheek Wrinkle Trial subgroup (NCT04124692). Largely manufacturer-linked (Galderma), stated as fact in the evidence panel.
6. Khoury et al. Systematic review and meta-analysis of facelift outcomes. Aesthetic Plastic Surgery, 2025. 21 studies, 2,896 patients; deep-plane satisfaction approximately 94%, SMAS approximately 88%.
7. Lampridou et al. Polynucleotides and skin quality: systematic review. Journal of Cosmetic Dermatology, 2025. 9 low-to-moderate-quality studies, n=219; skin-quality outcomes only, limited consensus.
8. Complications in Medical Aesthetics Collaborative (CMAC) guidance on management of HA-filler-induced vascular occlusion, Journal of Clinical and Aesthetic Dermatology; covering necrosis, blindness and stroke risk. Consistent with FDA dermal-filler safety reviews (2025).
9. FDA Safety Communication, Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling, 15 October 2025. Burns, scarring, fat loss, disfigurement, nerve damage.
10. Clinical studies and systematic reviews of autologous fat transfer retention, reporting approximately 32 to 41% retention at 16 to 17 months.
11. Remote-prescribing rule: from 1 June 2025, a face-to-face consultation is required before prescribing prescription-only medicines, including hyaluronidase, for non-surgical cosmetic procedures. NMC position; GMC, GDC and GPhC aligned; GPhC guidance updated April 2025.
12. The licensing of non-surgical cosmetic procedures in England: consultation response. GOV.UK, 7 August 2025. Red/Amber/Green tiering; confirmed in policy, not in force in 2026; England-focused, with further consultation expected.
13. Botulinum Toxin and Cosmetic Fillers (Children) Act 2021, in force 1 October 2021, England. Criminal offence including arranging or booking; consent is no defence.
14. MHRA position that injectable exosomes are unlicensed medicinal products and unlawful to inject in the UK; GPhC harm warning on "Lemon Bottle" and unlicensed fat-dissolvers, April 2025.
Medical review pending
Reviewer and review date to be assigned. A named medical reviewer is a priority for this page post-launch, given the vascular-risk content.